Discontinued — last reported Q4 '22
Other — Operating Income (Loss)
Boston Scientific Other — Operating Income (Loss) remained flat by 0.0% to -$15.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 1600.0%, from $1.00M to -$15.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates improved performance or reduced costs in non-core business areas, while a decrease suggests rising unallocated expenses or losses in peripheral operations.
Detailed definition
This metric represents the operating profit or loss generated by business activities that do not fall into the company's...
Peer comparison
Peers often report similar figures under 'Corporate and Other' or 'Unallocated' segments, where volatility is common due to corporate restructuring or accounting adjustments.
bsx_segment_other_operating_income_lossHistorical Data
| FY'21 | FY'22 | |
|---|---|---|
| Value | $4.00M | -$60.00M |
| YoY Change | — | <-999% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's other — operating income (loss)?
- Boston Scientific (BSX) reported other — operating income (loss) of -$15.00M in Q4 2022.
- How has Boston Scientific's other — operating income (loss) changed year-over-year?
- Boston Scientific's other — operating income (loss) decreased by 1600.0% year-over-year, from $1.00M to -$15.00M.
- What does other — operating income (loss) mean?
- The profit or loss generated by business activities that are not part of the company's main operating segments.